1 Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med. 2010;268:456–467.
2 The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration Writing and global analysis
group. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014;2:634–647.
3 Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 2018; 137:e467– e492.
4 Sarafidis PA, Li S, Chen SC, et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. 2008;121:332–340.
5 WheltonPK,CareyRM,AronowWS,etal.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248
6 WilliamsB,ManciaG,SpieringW,etal;ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104.
7 ShimamotoK,AndoK,FujitaT,etal;Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37(4):253-390.
8 Wang C , Deng W J , Gong W Y , et al. High prevalence of isolated nocturnal hypertension in Chinese patients with chronic kidney disease. J Am Heart Assoc, 2015, 4(6):e002025.
9 Wang C , Li Y , Zhang J , et al. Prognostic Effect of Isolated Nocturnal Hypertension in Chinese Patients With Nondialysis Chronic Kidney Disease. J Am Heart Assoc, 2016, 5(10):e004198.
10 Li Y, Deng Q, Li H, et al. Prognostic value of nighttime blood pressure load in Chinese patients with nondialysis chronic kidney disease. J Clin Hypertens (Greenwich), 2017, 19(9): 890-898.
11 Yang W Y, Melgarejo J D, Thijs L, et al.Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes. JAMA 2019; 322(5): 409-420.
12 Cha R H , Kim S , Ae Yoon S , et al. Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: results of the APrODiTe study. Hypertens Res, 2014, 37(2):172-178.
13 Drawz P E , Alper A B , Anderson A H , et al. Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage. Clin J Am Soc Nephrol, 2016:CJN.08530815.
14 Scheppach J B , Raff U , Toncar S , et al. Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease. Hypertension, 2018, 72(4):929-936.
15 Agarwal R. Arterial stiffness and its relationship to clinic and ambulatory blood pressure: a longitudinal study in non-dialysis chronic kidney disease. Nephrol Dial Transplant, 2017, 32(11):1850.
16 Li J, Wang F, Jian G, et al. Analysis of 24-hour ambulatory blood pressure monitoring in patients with diabetic nephropathy: a hospital-based study. Clin Nephrol, 2013, 79(3):199-205.
17 Chinese expert consensus on prevention and treatment of diabetic nephropathy (2014) [in Chinese]. Chin J Diabetes Mellitus. 2014,6(11):792-801.
18 Jha V, Garcia-Garcia G , Iseki K , et al. Chronic kidney disease: global dimension and perspectives. Lancet, 2013, 382(9888):260-272.
19 Franssen PM, Imholz BP: Evaluation of the Mobil-O-Graph new gen- eration ABPM device using the ESH criteria. Blood Press Monit 15: 229–231, 2010
20 Wei W, Tölle M, Zidek W, van der Giet M: Validation of the mobil- O-Graph: 24 h-blood pressure measurement device. Blood Press Monit 15: 225–228, 2010
21 Parati G, Stergiou G, O’Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.J Hypertens. 2014;32:1359–1366.
22 Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458.
23 Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
24 Liu LS. Writing Group of 2010 Chinese guidelines for the management of hypertension. 2010 Chinese guidelines for the management of hypertension [in Chinese]. Chin J Hypertens. 2011;19(8):701-742.
25 Fan HQ, Li Y, Thijs L,et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28:2036–2045.
26 O’BrienE,ParatiG,StergiouG,et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9): 1731-1768.
27 Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage. J Hypertens 2008;26:1919–1927.
28 Bliziotis IA, Destounis A, Stergiou GS. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30:1289–1299.
29 Drawz PE, Alper AB, Anderson AH, et al. Masked hypertension and elevated nighttime blood pressure in CKD: Prevalence and association with target organ damage. Clin J Am Soc Nephrol. 2016;11(4):642-652.
30 Scheppach J B , Raff U , Toncar S , et al. Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease. Hypertension, 2018, 72(4):929-936.
31 Zhang L , Long J , Jiang W , et al. Trends in Chronic Kidney Disease in China. N Engl J Med, 2016, 375(9):905-906.
32 Li J , Wang F , Jian G , et al. Analysis of 24-hour ambulatory blood pressure monitoring in patients with diabetic nephropathy: a hospital-based study. Clinical Nephrology, 2013, 79(3):199-205.
33 Tamura K , Yamauchi J , Tsurumi-Ikeya Y , et al. Ambulatory Blood Pressure and Heart Rate in Hypertensives with Renal Failure: Comparison between Diabetic Nephropathy and Non-Diabetic Glomerulopathy. Clin Exp Hypertens, 2008, 30(1):33-43.
34 Chen W. Clinical meaning of ambulatory blood pressure monitoring in patients with diabetic nephropathy [in Chinese]. Chin J Mod Drug Appl, 2012, (14):34-35.
35 Zhang W, Yuan J, Yuan H, et al. Comparison analysis of 24 h ambulatory blood pressure monitoring between
primary and secondary glomerular disease [in Chinese]. Journal of Shanghai Jiaotong University (medical science), 2013, 33(4):463-467.
36 Ying B, Shao X, Li Y, et al. Analysis of 24 h ambulatory blood pressure monitoring between
primary and secondary glomerular disease in children [in Chinese]. Guizhou Medical Journal, 2015(2):142-144.